Hugo M. Horlings: h-index, Total Citations, and Citation Map
Hugo M. Horlings's h-index is 63 (132 i10-index, 31,518+ total citations across 2+ publications) according to Google Scholar as of July 2026. Hugo M. Horlings is affiliated with MD PhD, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Hugo M. Horlings is a researcher affiliated with MD PhD, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands, specializing in Molecular pathology, therapy resistance, oncogenic pathways. Their work has been cited 31,518 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Hugo M. Horlings's Citation Metrics
Bibliometric impact based on 2 indexed publications.
- H-Index
- 63
- i10-Index
- 132
- Total Citations
- 31,518
- Citing Countries
- 10
As of July 2026.
Hugo M. Horlings has an h-index of 63 and 31,518 total citations across 2 publications, with research cited by institutions in 10 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Hugo M. Horlings's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
20106,226
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher identified the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer using a functional genetic approach.
The researcher established that the long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis, a seminal finding supported by over 6,000 citations.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Hugo M. Horlings's research
Hugo M. Horlings is a researcher in Molecular pathology, therapy resistance and oncogenic pathways at MD PhD, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Their work has been cited 31,518 times across 2 publications (h-index 63), according to Google Scholar.
Their most-cited work, “Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis” (2010), has accumulated 6,226 citations. Other influential work includes “A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer” (2007) with 2,016 citations.
Citations of Hugo M. Horlings's research come primarily from United States, China and Italy, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
